House Oversight Launches Probe Over Top-Dollar Drugs

The chairman of the U.S. House Committee on Oversight and Government Reform on Monday launched an investigation into drug pricing by sending letters to a dozen big-name drugmakers questioning how they...

Already a subscriber? Click here to view full article